Search - tctmd.com

Displaying 741 - 760 of 924

Sort: Relevancy | Date

News Industry News

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

May 23, 2013

News Industry News

Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures

May 23, 2013

News Industry News

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

May 22, 2013

News Industry News

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

May 21, 2013

News Daily News

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Caitlin E. Cox

May 17, 2013

News Industry News

CircuLite® Receives Approval to Begin CE Mark Trial for Synergy® IC Circulatory Support System

May 15, 2013

News Daily News

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Yael L. Maxwell

May 13, 2013

News Daily News

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

May 13, 2013

News Conference News AATS 2013

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

L.A. McKeown

May 07, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

Presentation

Transcatheter vs. Surgical Aortic Valve Replacement in Severe Aortic Stenosis: Echo Parameters in Cohort A of the PARTNER Trial

Presenter: Rebecca T. Hahn

April 24, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Yael L. Maxwell

April 12, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

Presentation ACC 2013

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: Vinod H. Thourani

March 11, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

L.A. McKeown

March 11, 2013

News Industry News

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

March 09, 2013

Advertisement

POSITIVE ANIMAL DATA PRESENTED AT EuroPCR SETS STAGE FOR ADVANCING NEOVASC’S TIARATM TRANSCATHETER MITRAL VALVE INTO HUMAN TRIALS

Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve Procedures

Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial

Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve Performance

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

CircuLite® Receives Approval to Begin CE Mark Trial for Synergy® IC Circulatory Support System

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Transcatheter vs. Surgical Aortic Valve Replacement in Severe Aortic Stenosis: Echo Parameters in Cohort A of the PARTNER Trial

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content